Healthcare >> Analyst Interviews >> October 5, 2000
JASON WITTES is an Equity Research Analyst covering the medical
technology industry within the Healthcare Research Group at UBS Warburg
LLC. Prior to joining UBS Warburg, he was a Research and Development
Scientist at Novartis and Pfizer. Mr. Wittes received a BS Chemistry
from Carnegie Mellon and an MBA from New York University's Stern School
of Business. Profile
analysis do you use?
Mr. Wittes: I look at two distinct types of companies. The first are
biomaterials companies. These
